Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01194323 · ClinicalTrials.gov registry record

Biology in Patients With Reflux Esophagitis

A clinical trial, sponsored by Vanderbilt University Medical Center.

Completed
Registry status
75
Enrollment target

NCT01194323: Completed study, sponsored by Vanderbilt University Medical Center.

NCT01194323 is a clinical trial that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 75 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01194323 has completed, sponsored by Vanderbilt University Medical Center.

COMPLETED
Registry status
75 participants
Enrollment target

Study Summary

GERD is a common condition in the western world. In most cases, the diagnostic is established by good response to empiric proton pump inhibitor (PPI) therapy. When the patient symptoms are refractory to therapy, multiple invasive tests are available. The results of those tests (EGD, manometry, Ph monitoring and impedance) are clues that the physician use together to establish the diagnostic. No test however can be use alone because of their poor specificity and sensitivity. Recently, microscopy has been used to detect dilated intercellular space in between distal esophageal cells tissue; unfortunately this marker again failed to diagnose GERD. In search of more sensitive and specific markers of GERD, we propose to assess if acid exposure affects: 1) gene and proteins expression in the esophageal/post-cricoid area tissue; and 2) local impedance of the mucosa. The secondary aim of this proposal is to determine if correlation exists between the two approaches.

Primary Outcome

We are assessing if acid exposure affects gene and protein expression in the esophageal/post-cricoid area tissue

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2010-11
Est. Completion 2012-12

What the finished NCT01194323 record still lists

NCT01194323 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 75 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT01194323 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01194323 about?

NCT01194323 is a clinical study titled "Biology in Patients With Reflux Esophagitis". GERD is a common condition in the western world. In most cases, the diagnostic is established by good response to empiric proton pump inhibitor (PPI) therapy. When the patient symptoms are refractory to therapy, multiple invasive tests are available. The results of those tests (EGD, manometry, Ph mo...

What is the current status of trial NCT01194323?

This trial is currently completed. The enrollment target is 75 participants. The study started on 2010-11. Estimated completion is 2012-12.

Who is sponsoring clinical trial NCT01194323?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01535430 · 75 participants

    Assessment of Eloquent Function in Brain Tumor Patients

  • NCT01542879 · 75 participants · Phase 1

    Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer

  • NCT02232191 · 75 participants · Phase 2

    Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients

  • NCT02754544 · 75 participants · NA

    Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01194323, the US trial registry maintained by the National Library of Medicine. NCT01194323 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.